Research & Development



  大軍出征從來都不是驚天動地的,他們只會默默地出征,然後帶著榮耀歸來,最後重新變成農夫,變成工匠,變成各色各樣的人。   人只有在吃了虧之後才會領悟到一些忽視了的美好過往。人人碰免费视频   可憐啊,且熬著吧,我舅舅只要在位一日,他就沒有一天好日子過。”人人摸   懷化公主急急的指著那碗白米飯道︰“拿過來,我看見上面似乎蓋了糖霜。”   “自保用。”人人看   大河就不一樣了,它九曲連環,環環相扣,遇弱愈強,遇強則柔,在高山峻嶺間奔騰咆哮,在平原沃野中卻寂靜無聲,只是一旦沖垮了堤壩,就會糜爛千里。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo